NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of The Vita Coco Company, Inc. (“Vita Coco” or the “Company”) (NASDAQ: COCO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
The investigation concerns whether Vita Coco and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On March 26, 2025, NINGI Research published a report alleging that Vita Coco has misled investors about its growth and operations. Among other allegations, the report asserts that Vita Coco is set to lose a key contract with Costco that represents roughly 25% of Vita Coco’s net sales. The report also claims that Vita Coco is facing internal operational issues including supply chain mismanagement, related-party transactions, and poor performance outside of its core coconut water business.
On this news, Vita Coco’s stock price fell $3.90 per share, or 11%, to close at $31.55 per share on March 26, 2025.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com
646-581-9980 ext. 7980
- EU’s Champions League: Sweden, Czech Republic, and Greece Score Big Against Smoking - July 3, 2025
- BITF DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Bitfarms Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 8 Deadline in Securities Class Action – BITF - July 2, 2025
- Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak - July 2, 2025
